ID   KC1G2_HUMAN             Reviewed;         415 AA.
AC   P78368; B5BU42; O00704; Q8WUB1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Casein kinase I isoform gamma-2;
DE            Short=CKI-gamma 2;
DE            EC=2.7.11.1;
GN   Name=CSNK1G2; Synonyms=CK1G2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=9403068; DOI=10.1006/geno.1997.4991;
RA   Kitabayashi A.N., Kusuda J., Hirai M., Hashimoto K.;
RT   "Cloning and chromosomal mapping of human casein kinase I gamma 2
RT   (CSNK1G2).";
RL   Genomics 46:133-137(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN BRAIN DEVELOPMENT.
RX   PubMed=15342122; DOI=10.1016/j.neulet.2004.06.054;
RA   Yinan M., Yu Q., Zhiyue C., Jianjun L., Lie H., Liping Z., Jianhui Z.,
RA   Fang S., Dingfang B., Qing L., Xiru W.;
RT   "Polymorphisms of casein kinase I gamma 2 gene associated with simple
RT   febrile seizures in Chinese Han population.";
RL   Neurosci. Lett. 368:2-6(2004).
RN   [8]
RP   FUNCTION AS MTA1 KINASE, INTERACTION WITH MTA1, SUBCELLULAR LOCATION,
RP   AND ENZYME REGULATION.
RX   PubMed=15077195; DOI=10.1038/sj.onc.1207569;
RA   Mishra S.K., Yang Z., Mazumdar A., Talukder A.H., Larose L., Kumar R.;
RT   "Metastatic tumor antigen 1 short form (MTA1s) associates with casein
RT   kinase I-gamma2, an estrogen-responsive kinase.";
RL   Oncogene 23:4422-4429(2004).
RN   [9]
RP   FUNCTION IN PER1 STABILITY.
RX   PubMed=15917222; DOI=10.1074/jbc.M502862200;
RA   Shirogane T., Jin J., Ang X.L., Harper J.W.;
RT   "SCFbeta-TRCP controls clock-dependent transcription via casein kinase
RT   1-dependent degradation of the mammalian period-1 (Per1) protein.";
RL   J. Biol. Chem. 280:26863-26872(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   FUNCTION AS SMAD3 KINASE, AND INTERACTION WITH SMAD3.
RX   PubMed=18794808; DOI=10.1038/onc.2008.337;
RA   Guo X., Waddell D.S., Wang W., Wang Z., Liberati N.T., Yong S.,
RA   Liu X., Wang X.-F.;
RT   "Ligand-dependent ubiquitination of Smad3 is regulated by casein
RT   kinase 1 gamma 2, an inhibitor of TGF-beta signaling.";
RL   Oncogene 27:7235-7247(2008).
RN   [12]
RP   FUNCTION AS COL4A3BP/CERT KINASE.
RX   PubMed=19005213; DOI=10.1091/mbc.E08-07-0669;
RA   Tomishige N., Kumagai K., Kusuda J., Nishijima M., Hanada K.;
RT   "Casein kinase I{gamma}2 down-regulates trafficking of ceramide in the
RT   synthesis of sphingomyelin.";
RL   Mol. Biol. Cell 20:348-357(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 43-353 IN COMPLEX WITH
RP   5-IODOTUBERCIDIN.
RA   Bunkoczi G., Rellos P., Das S., Ugochukwu E., Fedorov O., Sobott F.,
RA   Eswaran J., Amos A., Ball L., Von Delft F., Bullock A., Debreczeni J.,
RA   Turnbull A., Sundstrom M., Weigelt J., Arrowsmith C., Edwards A.,
RA   Knapp S.;
RT   "The structure of casein kinase 1 gamma 2.";
RL   Submitted (JUL-2011) to the PDB data bank.
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-189; GLY-194; THR-196; CYS-206;
RP   HIS-206; SER-207; GLN-208; CYS-217 AND MET-223.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase. Casein kinases are
CC       operationally defined by their preferential utilization of acidic
CC       proteins such as caseins as substrates. It can phosphorylate a
CC       large number of proteins. Participates in Wnt signaling.
CC       Phosphorylates COL4A3BP/CERT, MTA1 and SMAD3. Involved in brain
CC       development and vesicular trafficking and neurotransmitter
CC       releasing from small synaptic vesicles. Regulates fast synaptic
CC       transmission mediated by glutamate. SMAD3 phosphorylation promotes
CC       its ligand-dependent ubiquitination and subsequent proteasome
CC       degradation, thus inhibiting SMAD3-mediated TGF-beta responses.
CC       Hyperphosphorylation of the serine-repeat motif of COL4A3BP/CERT
CC       leads to its inactivation by dissociation from the Golgi complex,
CC       thus down-regulating ER-to-Golgi transport of ceramide and
CC       sphingomyelin synthesis. Triggers PER1 proteasomal degradation
CC       probably through phosphorylation. {ECO:0000269|PubMed:15077195,
CC       ECO:0000269|PubMed:15342122, ECO:0000269|PubMed:15917222,
CC       ECO:0000269|PubMed:18794808, ECO:0000269|PubMed:19005213}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Stimulated by estrogen. Repressed by 5-
CC       iodotubercidin (DB04604). {ECO:0000269|PubMed:15077195}.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with MTA1 (short
CC       isoform) in the cytoplasm. Interacts with SMAD3. {ECO:0000250,
CC       ECO:0000269|PubMed:15077195, ECO:0000269|PubMed:18794808,
CC       ECO:0000269|Ref.16}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-748380, EBI-743771;
CC       Q9Y5P4:COL4A3BP; NbExp=4; IntAct=EBI-748380, EBI-739994;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-748380, EBI-10172290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15077195}.
CC   -!- TISSUE SPECIFICITY: Testis.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U89896; AAB88627.1; -; mRNA.
DR   EMBL; BT009922; AAP88924.1; -; mRNA.
DR   EMBL; AF001177; AAC00212.1; -; Transcribed_RNA.
DR   EMBL; AB451278; BAG70092.1; -; mRNA.
DR   EMBL; AB451410; BAG70224.1; -; mRNA.
DR   EMBL; AC005306; AAC26983.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69430.1; -; Genomic_DNA.
DR   EMBL; BC018693; AAH18693.1; -; mRNA.
DR   EMBL; BC018699; AAH18699.1; -; mRNA.
DR   EMBL; BC020972; AAH20972.1; -; mRNA.
DR   CCDS; CCDS12077.1; -.
DR   RefSeq; NP_001310.3; NM_001319.6.
DR   UniGene; Hs.651905; -.
DR   PDB; 2C47; X-ray; 2.40 A; A/B/C/D=43-353.
DR   PDBsum; 2C47; -.
DR   ProteinModelPortal; P78368; -.
DR   SMR; P78368; -.
DR   BioGrid; 107839; 30.
DR   IntAct; P78368; 12.
DR   MINT; MINT-1473562; -.
DR   STRING; 9606.ENSP00000255641; -.
DR   BindingDB; P78368; -.
DR   ChEMBL; CHEMBL2543; -.
DR   DrugBank; DB04604; 5-iodotubercidin.
DR   DrugBank; DB03083; IC261.
DR   DrugBank; DB03693; N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide.
DR   GuidetoPHARMACOLOGY; 2000; -.
DR   iPTMnet; P78368; -.
DR   PhosphoSitePlus; P78368; -.
DR   SwissPalm; P78368; -.
DR   BioMuta; CSNK1G2; -.
DR   DMDM; 3024060; -.
DR   EPD; P78368; -.
DR   MaxQB; P78368; -.
DR   PaxDb; P78368; -.
DR   PeptideAtlas; P78368; -.
DR   PRIDE; P78368; -.
DR   DNASU; 1455; -.
DR   Ensembl; ENST00000255641; ENSP00000255641; ENSG00000133275.
DR   GeneID; 1455; -.
DR   KEGG; hsa:1455; -.
DR   UCSC; uc002lul.5; human.
DR   CTD; 1455; -.
DR   DisGeNET; 1455; -.
DR   GeneCards; CSNK1G2; -.
DR   HGNC; HGNC:2455; CSNK1G2.
DR   HPA; HPA034868; -.
DR   HPA; HPA056572; -.
DR   MIM; 602214; gene.
DR   neXtProt; NX_P78368; -.
DR   OpenTargets; ENSG00000133275; -.
DR   PharmGKB; PA26955; -.
DR   eggNOG; KOG1165; Eukaryota.
DR   eggNOG; ENOG410XNXP; LUCA.
DR   GeneTree; ENSGT00760000119040; -.
DR   HOGENOM; HOG000182054; -.
DR   HOVERGEN; HBG000176; -.
DR   InParanoid; P78368; -.
DR   KO; K08958; -.
DR   OMA; SINRYID; -.
DR   OrthoDB; EOG091G0F3Z; -.
DR   PhylomeDB; P78368; -.
DR   TreeFam; TF313349; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   SignaLink; P78368; -.
DR   SIGNOR; P78368; -.
DR   ChiTaRS; CSNK1G2; human.
DR   EvolutionaryTrace; P78368; -.
DR   GenomeRNAi; 1455; -.
DR   PRO; PR:P78368; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000133275; -.
DR   CleanEx; HS_CSNK1G2; -.
DR   ExpressionAtlas; P78368; baseline and differential.
DR   Genevisible; P78368; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0001948; F:glycoprotein binding; IEA:Ensembl.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:Ensembl.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; IBA:GO_Central.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN         1    415       Casein kinase I isoform gamma-2.
FT                                /FTId=PRO_0000192842.
FT   DOMAIN       46    316       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      52     60       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    165    165       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      75     75       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VARIANT     189    189       F -> L (in dbSNP:rs55702630).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042086.
FT   VARIANT     194    194       E -> G (in dbSNP:rs55780547).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042087.
FT   VARIANT     196    196       I -> T (in dbSNP:rs55923222).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042088.
FT   VARIANT     206    206       Y -> C (in dbSNP:rs56264133).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042089.
FT   VARIANT     206    206       Y -> H (in dbSNP:rs56108438).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042090.
FT   VARIANT     207    207       R -> S (in dbSNP:rs56340103).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042091.
FT   VARIANT     208    208       E -> Q (in dbSNP:rs55818316).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042092.
FT   VARIANT     217    217       R -> C (in dbSNP:rs55754218).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042093.
FT   VARIANT     223    223       T -> M (in dbSNP:rs56038081).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042094.
FT   CONFLICT    113    113       K -> N (in Ref. 2; AAP88924 and 6;
FT                                AAH20972). {ECO:0000305}.
FT   STRAND       46     51       {ECO:0000244|PDB:2C47}.
FT   STRAND       60     65       {ECO:0000244|PDB:2C47}.
FT   TURN         66     68       {ECO:0000244|PDB:2C47}.
FT   STRAND       71     78       {ECO:0000244|PDB:2C47}.
FT   HELIX        86     95       {ECO:0000244|PDB:2C47}.
FT   TURN         96     98       {ECO:0000244|PDB:2C47}.
FT   STRAND      105    111       {ECO:0000244|PDB:2C47}.
FT   STRAND      114    120       {ECO:0000244|PDB:2C47}.
FT   HELIX       126    132       {ECO:0000244|PDB:2C47}.
FT   TURN        133    135       {ECO:0000244|PDB:2C47}.
FT   HELIX       139    158       {ECO:0000244|PDB:2C47}.
FT   HELIX       168    170       {ECO:0000244|PDB:2C47}.
FT   STRAND      171    173       {ECO:0000244|PDB:2C47}.
FT   TURN        179    182       {ECO:0000244|PDB:2C47}.
FT   STRAND      183    186       {ECO:0000244|PDB:2C47}.
FT   STRAND      193    196       {ECO:0000244|PDB:2C47}.
FT   TURN        198    200       {ECO:0000244|PDB:2C47}.
FT   TURN        216    218       {ECO:0000244|PDB:2C47}.
FT   HELIX       221    224       {ECO:0000244|PDB:2C47}.
FT   HELIX       231    247       {ECO:0000244|PDB:2C47}.
FT   TURN        251    254       {ECO:0000244|PDB:2C47}.
FT   STRAND      257    259       {ECO:0000244|PDB:2C47}.
FT   HELIX       260    272       {ECO:0000244|PDB:2C47}.
FT   HELIX       276    279       {ECO:0000244|PDB:2C47}.
FT   TURN        280    282       {ECO:0000244|PDB:2C47}.
FT   HELIX       285    295       {ECO:0000244|PDB:2C47}.
FT   HELIX       305    318       {ECO:0000244|PDB:2C47}.
FT   TURN        328    331       {ECO:0000244|PDB:2C47}.
SQ   SEQUENCE   415 AA;  47457 MW;  036A39148A1DA038 CRC64;
     MDFDKKGGKG ETEEGRRMSK AGGGRSSHGI RSSGTSSGVL MVGPNFRVGK KIGCGNFGEL
     RLGKNLYTNE YVAIKLEPIK SRAPQLHLEY RFYKQLSATE GVPQVYYFGP CGKYNAMVLE
     LLGPSLEDLF DLCDRTFTLK TVLMIAIQLI TRMEYVHTKS LIYRDVKPEN FLVGRPGTKR
     QHAIHIIDFG LAKEYIDPET KKHIPYREHK SLTGTARYMS INTHLGKEQS RRDDLEALGH
     MFMYFLRGSL PWQGLKADTL KERYQKIGDT KRATPIEVLC ENFPEEMATY LRYVRRLDFF
     EKPDYDYLRK LFTDLFDRSG FVFDYEYDWA GKPLPTPIGT VHTDLPSQPQ LRDKTQPHSK
     NQALNSTNGE LNADDPTAGH SNAPITAPAE VEVADETKCC CFFKRRKRKS LQRHK
//
